 Lauren McLemore
Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 4 | 2025 | 2294 | 0.710 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 63 | 0.580 |
Why?
| | Neoadjuvant Therapy | 2 | 2023 | 409 | 0.520 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 206 | 0.500 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 216 | 0.500 |
Why?
| | Antigens, CD | 1 | 2018 | 537 | 0.470 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 433 | 0.460 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1237 | 0.460 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1399 | 0.380 |
Why?
| | Keratin-15 | 1 | 2025 | 16 | 0.240 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2025 | 68 | 0.230 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 98 | 0.230 |
Why?
| | Comprehension | 1 | 2025 | 175 | 0.200 |
Why?
| | Health Literacy | 1 | 2025 | 170 | 0.200 |
Why?
| | Receptor, ErbB-2 | 2 | 2023 | 355 | 0.190 |
Why?
| | Artificial Intelligence | 1 | 2025 | 295 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 530 | 0.170 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 310 | 0.160 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 502 | 0.130 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1734 | 0.130 |
Why?
| | Retrospective Studies | 2 | 2021 | 15924 | 0.090 |
Why?
| | Registries | 1 | 2018 | 2054 | 0.080 |
Why?
| | Female | 6 | 2025 | 74078 | 0.070 |
Why?
| | Metaplasia | 1 | 2025 | 58 | 0.060 |
Why?
| | Gyrus Cinguli | 1 | 2006 | 93 | 0.060 |
Why?
| | Cell Plasticity | 1 | 2025 | 37 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2006 | 160 | 0.060 |
Why?
| | Reading | 1 | 2025 | 136 | 0.050 |
Why?
| | Brain Mapping | 1 | 2006 | 524 | 0.050 |
Why?
| | Breast | 1 | 2023 | 158 | 0.050 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2023 | 377 | 0.050 |
Why?
| | Humans | 5 | 2025 | 139073 | 0.040 |
Why?
| | Schizophrenia | 1 | 2006 | 451 | 0.040 |
Why?
| | Aged | 1 | 2018 | 24237 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3408 | 0.030 |
Why?
| | Middle Aged | 1 | 2018 | 33867 | 0.030 |
Why?
| | Adult | 1 | 2018 | 38394 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4339 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 4024 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1748 | 0.030 |
Why?
| | Mice | 1 | 2025 | 17867 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2006 | 98 | 0.010 |
Why?
| | Atrophy | 1 | 2006 | 189 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2006 | 560 | 0.010 |
Why?
| | Animals | 1 | 2025 | 37352 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 566 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2006 | 510 | 0.010 |
Why?
| | Male | 2 | 2025 | 68330 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 755 | 0.010 |
Why?
| | Sex Factors | 1 | 2006 | 2056 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2006 | 2846 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 3276 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3651 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7660 | 0.010 |
Why?
| | Adolescent | 1 | 2006 | 21561 | 0.000 |
Why?
|
|
McLemore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|